硫酸氧钒 | 27774-13-6

• 物质功能分类: 无机化工 - 无机盐 - 金属硫化物及硫酸盐
• 分子结构分类: 无机化合物 - 混合金属/非金属化合物 - 过渡金属氧阴离子化合物
• 中文名称: 硫酸氧钒
• 中文别名: 氧代(硫酸(2-)-O)钒；硫酸氧化钒(IV)水合物；硫酸钒酰、硫酸钒；硫酸钒酰
• 英文名称: vanadyl sulphate
• 英文别名: vanadyl sulfate；vanadyl sulphate VOSO4, β；oxovanadium(2+);sulfate
• CAS: 27774-13-6
• 化学式: OV*O₄S
• 分子量: 163.005
• InChiKey: UUUGYDOQQLOJQA-UHFFFAOYSA-L

物化性质

• 熔点：
  105°C
• 密度：
  2.06[at 20℃]
• 溶解度：
  溶于H2O
• LogP：
  -1.031 (est)
• 物理描述：
  Vanadyl sulfate appears as a blue crystalline solid. Very soluble in water. Denser than water. Contact may irritate skin, eyes, and mucous membranes. May be toxic by ingestion, inhalation and skin absorption.
• 稳定性/保质期：

  在常温常压下稳定，避免接触强氧化剂。它不溶于水，可与硫酸铵或碱金属硫酸盐生成复合盐。

• 分解：
  When heated to decomposition it emits toxic fumes of /vanadium and sulfur oxides/.

计算性质

• 辛醇/水分配系数(LogP)：
  -1.46
• 重原子数：
  7
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  106
• 氢给体数：
  0
• 氢受体数：
  5

ADMET

代谢

在生物体的组织中，由于存在大量的还原条件，V3+ 和 V4+ 占主导地位；然而，在富含氧气的血浆中，形成了 V5+。

Within tissues in organisms, V3+ and V4+ predominate because of largely reducing conditions; in plasma, however, which is high in oxygen, V5+ is formed.

来源:Hazardous Substances Data Bank (HSDB)

代谢

钒主要通过吸入被吸收，尽管少量可以通过皮肤和消化道吸收。它在血浆中迅速分布，主要分布到肾脏、肝脏、肺、心脏、骨骼等部位，并倾向于在这些部位积累。在细胞色素P-450酶的帮助下，钒可以在其两种氧化态之间相互转化，即钒(IV)（V+4）和钒酸根（V+5）。钒的这两种状态都可以与血液中的转铁蛋白可逆地结合，然后被红细胞摄取。钒主要通过尿液排出体外。(L837)

Vanadium is absorbed mainly via inhalation, though small amounts can be absorbed through the skin and gastrointestional tract. It is rapidly distributed in the plasma, mainly to the kidney, liver, lungs, heart, bone, where it tends to accumulate. With the help of cytochrome P-450 enzymes, it can interconvert between its two oxidation states, vanadyl (V+4) and vanadate (V+5). Both states of vanadium can reversibly bind to transferrin protein in the blood and then be taken up into erythrocytes. Vanadium is excreted mainly in the urine. (L837)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 毒性总结

硫酸钒是一种淡蓝色粉末。它被用作染料和印花纺织品的中介剂；彩色玻璃的制造；陶器上的蓝色和绿色釉料。其它用途包括催化剂；苯胺黑制剂；还原剂。硫酸钒已被测试为糖尿病的实验性治疗。人体暴露和毒性：治疗组（11名男性；4名女性）口服硫酸钒0.5毫克/千克体重/天，持续12周，对照组（12名男性；4名女性）接受安慰剂胶囊。研究结束时，各组在体重、血压、标准血液学指标、血液粘度或标准血液生化测量方面没有显著差异。硫酸钒在人类淋巴细胞微核试验中呈阳性。硫酸钒在人类正常淋巴细胞和海拉细胞中诱导DNA损伤。动物研究：将硫酸钒五水合物给予大鼠和小鼠。中毒后出现的临床和物理体征包括呼吸不规则、腹泻、共济失调和后腿瘫痪。大鼠长期暴露于硫酸钒，最初通过母乳，后来在饮水中，10周后在肾脏中显著增加了丙二醛的形成，但其他组织没有。在大鼠和小鼠的急性和慢性研究中，没有检测到钒处理在脑、心、肺、脾或肝中显著增加的脂质过氧化。在饮水中给予雄性大鼠不同剂量的硫酸钒，相当于34、54和90毫克/千克体重/天，持续52周，没有显示出严重的系统性毒性迹象。给雄性大鼠口服VOSO4，31毫克V/千克体重/天，持续60天，导致生殖器官重量、精子计数和活力下降，以及生精小管的萎缩。大鼠在妊娠晚期和哺乳期通过饮水暴露于10毫克V/千克体重的VOSO4，直到出生后第100天。观察到存活率下降，存活后代记录了行为效应。在妊娠第6-15天通过灌胃给予VOSO4的小鼠的后代中，观察到早期吸收显著增加和胎儿生长减少。在15和30毫克Va/千克体重的剂量下，腭裂增加。所有剂量水平下，小颌和骨化延迟增加。在活体中，VOSO4在小鼠骨髓中诱导了染色体畸变和与非整倍体相关的终点（低倍性和高倍性），在单次胃内给药100毫克VOSO4/千克（31毫克V/千克）后。在存在和不存在代谢激活的情况下，硫酸钒在420至1000毫摩尔/升的剂量水平下，在S. cerevisiae的D7株中没有诱导转化或回复。此外，在存在和不存在代谢激活的情况下，在0至7.5毫摩尔/升的剂量水平下，没有检测到哈姆斯特V79细胞的致突变活性。

IDENTIFICATION AND USE: Vanadyl sulfate is a pale blue powder. It is used as mordant in dyeing and printing textiles; manufacture of colored glass; for blue and green glazes on pottery. It's other uses include catalyst; aniline black preparation; reducing agent. Vanadyl sulfate has been tested as an experimental therapy in diabetes. HUMAN EXPOSURE AND TOXICITY: The treatment group (11 males; 4 females) was orally administered vanadyl sulfate 0.5 mg/kg bw/day for 12 weeks, and a control group (12 males; 4 females) received placebo capsules. At the end of the study, there were no significant differences between the groups in terms of body weight, blood pressure, standard hematological indices, blood viscosity, or standard blood biochemistry measurements. Vanadyl sulfate was positive in human lymphocyte micronucleus assay. Vanadyl sulfate induced DNA damage in human normal lymphocytes and in HeLa cells. ANIMAL STUDIES: Vanadyl sulfate pentahydrate were administered to rats and mice. The clinical and physical signs appearing after the intoxication include irregular respiration, diarrhea, ataxia, and paralysis of the hind legs. Chronic exposure of rats to vanadium sulfate, initially through maternal milk and later in the drinking water, resulted after 10 weeks in a significant increase in malondialdehyde formation by kidney but not by other tissues. In both acute and chronic studies in rats and mice, no significant increase in lipid peroxidation by vanadium treatment was detected in brain, heart, lung, spleen, or liver. Treatment of male rats with different dose levels of vanadyl sulfate in drinking water corresponding to 34, 54, and 90 mg/kg bw/day over 52 weeks did not indicate severe signs of systemic toxicity. Peroral administration to male rats of VOSO4, 31 mg V/kg body weight/day for 60 days, caused a decrease in reproductive organ weight, sperm count, and motility, as well as atrophy of the seminiferous tubules. Rats were exposed to 10 mg V/kg body weight/day as VOSO4 in drinking water during late gestation and lactation until postnatal day 100. Decreases in survival were observed and behavioral effects recorded in surviving offspring. A significant increase in early resorptions and decrease in fetal growth was observed in the offspring of mice administered VOSO4 by gavage on gestation days 6-15 in doses from 7.5 mg V/kg body weight/day. Cleft palate was increased at 15 and 30 mg Va/kg body weight/day. Micrognathia and delayed ossification was increased at all dose levels. In vivo, VOSO4 induced chromosomal aberrations and aneuploidy-related endpoints (hypoploidy and hyperploidy) in mice bone marrow after a single intragastric dose of 100 mg VOSO4/kg (31 mg V/kg). Vanadyl sulfate induced no convertants or revertants in the D7 strain of S. cerevisiae at dose levels between 420 and 1000 mmol/L in both the presence and absence of metabolic activation. Also, no mutagenic activity was detected in hamster V79 cells at dose levels between 0 and 7.5 mmol/L in both the presence and absence of metabolic activation.

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 毒性总结

钒通过降低巨噬细胞膜的完整性来损害肺泡巨噬细胞，从而影响细胞的吞噬能力和生存能力。钒的五价形式，钒酸盐，是血浆膜上Ca2+-ATP酶和Na+,K+-ATP酶的强效抑制剂，它降低了细胞内ATP的浓度。还认为钒能诱导活性氧种类的产生。这可能会损害DNA并导致氧化应激，从而损害生殖系统。钒还抑制蛋白质酪氨酸磷酸酶，产生类似胰岛素的作用。

Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent form of vanadium, vanadate, is a potent inhibitor of the Ca+-ATPase and Na+,K+-ATPase of plasma membranes, which decreases intracellular ATP concentration. Vanadium is also believed to induce the production of reactive oxygen species. This may damage DNA and also cause oxidative stress, which can damage the reproductive system. Vanadium also inhibits protein tyrosine phosphatases, producing insulin-like effects. (L837, A247, A248, A249, A250, A251)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 致癌物分类

对人类不具有致癌性（未被国际癌症研究机构IARC列名）。

No indication of carcinogenicity to humans (not listed by IARC).

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 健康影响

吸入高浓度的钒会影响肺部、喉咙和眼睛。摄入钒可能会导致肾脏和肝脏损伤、出生缺陷或死亡。

Breathing high levels of vanadium affects the lungs, throat, and eyes. Ingestion of vanadium may cause kidney and liver damage, birth defects, or death. (L837)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 暴露途径

口服（L837）；吸入（L837）；皮肤给药（L837）

Oral (L837) ; inhalation (L837) ; dermal (L837)

来源:Toxin and Toxin Target Database (T3DB)

吸收、分配和排泄

该研究使用了高剂量的硫酸氧钒（相当于每公斤体重7.56和15.12毫克的钒），这些剂量与用于展示其抗糖尿病活性的剂量相同。绝对生物利用度，即口服或静脉给药后钒的AUC ext（曲线下面积）的比率，在两个剂量之间相似（15.7%和16.4%），这表明对于药理活性剂量，硫酸氧钒的实际生物利用度相对较高且不依赖于剂量。

The study used higher doses of vanadyl sulfate (equivalent to 7.56 and 15.12 mg V/kg), which are within the same dose range as doses used for demonstrating its anti-diabetic activity. Absolute bioavailability, calculated as ratio of vanadium AUC ext after oral or iv administration, were similar between doses (15.7% and 16.4%), indicating that for pharmacologically active doses vanadyl sulfate actual bioavailability is relatively high and not dose-dependent.

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

硫酸钒作为膳食钒，在大鼠组织中被保留：心脏>脾>甲状腺>肺>肾脏；在大鼠组织中，大约10%的注射剂量被保留。骨骼保留大约50%，这可能是因为钒酸盐与磷酸盐同构。

Dietary vanadium as vanadyl sulfate is retained in rat tissues: heart >spleen >thyroid >lung >kidney; about 10% of the injected dose is retained in the tissues in experimental animals. Bone retains about 50% of it, presumably because vanadates are isomorphic with phosphates.

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

大鼠平均吸收了0.5%口服给药的硫酸钒。

Rats absorbed an average of 0.5% of orally administered vanadyl sulfate.

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

大蒜植物（Allium sativum）在30°C的温度下，于5 mM硫酸钙水溶液中发芽4天。然后将植物悬浮在硫酸氧钒水溶液中（浓度范围1.6x10-4至5.0x10-3 M，体积：50 mL，初始pH大约为3-4）。经过不同的时间孵化，从10分钟到8天不等，取出植物样本并清洗。将它们的根、蒜瓣和叶子剪下，并立即进行电子自旋共振（ESR）光谱分析。对ESR参数的检查排除了VO(H2O)5 +2物种的存在，并表明离子几乎完全与低分子量的配体结合。...大多数吸附的VO+2离子以可溶的低分子量邻二酚化合物复合物的形式积累在根部。然而，随着浓度的增加，也检测到了可能与酸性多糖成分相关的固定氧钒(IV)离子。当植物暴露于含有VO+2和EDTA（配体与金属的摩尔比为1:1）的溶液中时，根部的光谱仅显示出可溶VO(EDTA)复合物的各向同性信号，并且它们足够流动，可以大量转移到顶部。/硫酸氧钒水溶液/

Plants of garlic (Allium sativum) were germinated at 30 °C in a 5 mM calcium sulfate aqueous solution for 4 days. Plants were then suspended in vanadyl oxide sulfate aqueous solutions (concentration range 1.6x10-4 to 5.0x10-3 M, volume: 50 mL and initial pH approx 3-4). After timed incubations, varying from 10 min to 8 days, plant samples were removed from solution and washed. Their roots, cloves, and leaves were cut and immediately subjected to ESR spectroscopy. Examination of the ESR parameters allowed exclusion of the presence of VO(H2O)5 +2 species and indicated that the ions were almost totally bound to ligands having low molecular weights. ... Most of adsorbed VO+2 ions accumulated in the root as soluble low molecular weight complexes of o-diphenolic compounds. However, with increasing concentration, immobilized oxovanadium(IV) ions, possibly associated with acid polysaccharide components, were also detected. When plants were exposed to solutions containing VO+2 and EDTA (ligand-to-metal molar ratio= 1:1) spectra of roots showed only the isotropic signals of the soluble VO(EDTA) complex, and they are mobile enough to be extensively translocated to the tops. /Vanadyl oxide sulfate aqueous solution/

来源:Hazardous Substances Data Bank (HSDB)

安全信息

• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R22
• 危险品运输编号：
  UN 2931/9152
• 海关编码：
  2825309000
• 包装等级：
  II
• 危险类别：
  6.1

SDS

Name:	Vanadyl Sulfate Material Safety Data Sheet
Synonym:	Vanadium, Oxo[sulfato(2-)-O]-; Vanadium, Oxosulfato-; Vanadium Oxide Sulfate; Vanadium Oxylsulfate; Oxo(sulfato)vanadium; Vanadium
CAS:	27774-13-6

Section 1 - Chemical Product MSDS Name:Vanadyl Sulfate Material Safety Data Sheet
Synonym:Vanadium, Oxo[sulfato(2-)-O]-; Vanadium, Oxosulfato-; Vanadium Oxide Sulfate; Vanadium Oxylsulfate; Oxo(sulfato)vanadium; Vanadium

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
27774-13-6	Vanadyl sulfate	100.0	248-652-7

Hazard Symbols: XN
Risk Phrases: 22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
May cause eye irritation and possible damage.
Skin:
Contact with skin causes irritation and possible burns, especially if the skin is wet or moist. Contact with the skin may cause skin lesions which are characterized by cracking of the skin and the development of slow-healing ulcers.
Ingestion:
May cause severe gastrointestinal tract irritation with nausea, vomiting and possible burns. May cause liver and kidney damage. May cause central nervous system effects and/or neurological effects.
May cause greenish-black tongue discoloration due to deposition of vanadium salts. Ingestion of large amounts may cause an increase in blood pressure.
Inhalation:
May cause liver and kidney damage. May cause irritation of the respiratory tract with burning pain in the nose and throat, coughing, wheezing, shortness of breath and pulmonary edema.
Chronic:
Chronic inhalation may cause effects similar to those of acute inhalation. May cause liver and kidney damage. May produce scattered allergy-like eczematous skin lesions symptomatic of vanadium toxicity.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Green coloration of the tongue, resulting from the deposition of vanadium salts is an indicator of exposure; however, may be absent even in prolonged exposure..
Antidote: There exists several chelation agents. The determination of there use should be made only by qualified medical personnel.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use extinguishing media appropriate to the surrounding fire. Substance is noncombustible.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to extinguish surrounding fire.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Do not get on skin or in eyes. Do not ingest or inhale. Discard contaminated shoes.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible substances. Keep containers tightly closed.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 27774-13-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: blue
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not applicable.
Freezing/Melting Point: Decomposes.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Very soluble in water.
Specific Gravity/Density: 3.0
Molecular Formula: VOSO4
Molecular Weight: 162.9985

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Sulfur oxides (SOx), including sulfur oxide and sulfur dioxide, vanadium oxide (VOx) gases.
Hazardous Polymerization: Will not occur.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 27774-13-6: YW1925000 LD50/LC50:
CAS# 27774-13-6: Skin, rabbit: LD50 = 4450 mg/kg.
Carcinogenicity:
Vanadyl sulfate - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

---

Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: Bluegill/Sunfish: 6mg/L; 96H Other For more information, see "HANDBOOK OF ENVIRONMENTAL FATE AND EXPOSURE DATA."

---

Section 13 - DISPOSAL CONSIDERATIONS
Products which are considered hazardous for supply are classified as Special Waste and the disposal of such chemicals is covered by regulations which may vary according to location. Contact a specialist disposal company or the local waste regulator for advice. Empty containers must be decontaminated before returning for recycling.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: VANADYL SULPHATE
Hazard Class: 6.1
UN Number: 2931
Packing Group: II
IMO
Shipping Name: VANADYL SULPHATE
Hazard Class: 6.1
UN Number: 2931
Packing Group: II
RID/ADR
Shipping Name: VANADYL SULPHATE
Hazard Class: 6.1
UN Number: 2931
Packing group: II
USA RQ: CAS# 27774-13-6: 1000 lb final RQ; 454 kg final RQ

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
WGK (Water Danger/Protection)
CAS# 27774-13-6: No information available.
Canada
CAS# 27774-13-6 is listed on Canada's DSL List.
CAS# 27774-13-6 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 27774-13-6 is listed on the TSCA inventory.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

无机化合物硫酸氧钒(IV)是钒常见的无机化合物，最常见的是三水合物和五水合物。这种物质在湿空气中极易潮解，外观为蓝色结晶，在实验室中常用作稳定且常用的钒盐。

化学性质上，硫酸氧钒又名硫酸氧化钒，其分子式为VOSO4·2H2O，分子量199.05。它是易溶于水的蓝色结晶性粉末。除了二水硫酸氧钒，还存在三水硫酸氧钒，在200℃时会转化为无水物。不溶入水中，但能与硫酸铵或碱金属硫酸盐生成复盐。五氧化二钒可溶解在冷浓硫酸中，通过二氧化硫还原制得。

用途方面，硫酸氧钒被用作媒染剂、催化还原剂及陶瓷、玻璃的着色剂。同时，它还用作催化剂和织物的媒染剂，并用于制造有色玻璃和陶器等产品。

生产方法上，采用阴极还原法，在二氧化硫溶液中将溶解于硫酸中的五氧化二钒通过阴极还原制得。

该化合物属于有毒物品，其毒性分级为高毒。急性毒性方面，腹注-小鼠 LD50 为114毫克/公斤。它不可燃，但在火场会产生有毒含钒、硫氧化物烟雾。储存和运输时需注意库房通风低温干燥，并与酸类或食品分开存储。

职业卫生标准：TLV-TWA为0.05毫克(五氧化二钒)/立方米；STEL为0.25毫克(五氧化二钒)/立方米。

反应信息

• 作为反应物：
  描述：

  硫酸氧钒 以 neat (no solvent) 为溶剂， 生成 vanadia
  参考文献：
  名称：

  Krasil'nikov, V. N.; Glazyrin, M. P., Russian Journal of Inorganic Chemistry, 1989, vol. 34, p. 191 - 193

  摘要：

  DOI：
• 作为产物：
  描述：

  sodium oxodisulfatovanadate(V) 生成 硫酸氧钒
  参考文献：
  名称：

  Krasil'nikov, V. N.; Glazyrin, M. P.; Palkin, A. P., Russian Journal of Inorganic Chemistry, 1987, vol. 32, p. 425 - 428

  摘要：

  DOI：
• 作为试剂：
  描述：

  苯乙醇 、 乙酸酐 在 硫酸氧钒 碳酸氢钠 、 Brine 、 magnesium sulfate 、 crude product 、 silica gel 作用下， 以 乙腈 为溶剂， 反应 24.17h， 以to yield 150.9 mg of 2-phenethyl acetate (92%) as colorless oil的产率得到乙酸苯乙酯
  参考文献：
  名称：

  Process for acyl substitution of anhydride by vanadyl salt catalyst

  摘要：

  一种酰基取代反应的过程，该过程包括在钒盐催化剂的存在下，将酐与含活性氢的化合物反应，以获得高收率的酰基取代反应产物和高化学选择性。

  公开号：

  US06541659B1

文献信息

• Lithium electrochemical intercalation in β-VOSO4
  作者：J. Gaubicher、Y. Chabre、J. Angenault、A. Lautié、M. Quarton

  DOI：10.1016/s0925-8388(97)00325-3

  日期：1997.11

  characterized by XRD as well as IR and Raman spectroscopy. From potentio-dynamic and galvano-static electrochemical studies it is shown that intercalation occurs in two steps, firstly with a structural change at 2.84 vs. Li metal, then in a solid solution domain. The process appears partly reversible and the system is shown to present a good cycling behavior on almost 0.6 c per transition metal. From these

  摘要 提出了一种新的低温合成β-VOSO 4 路线，包括在硫存在下还原硫酸。锂嵌入已经在这种材料上进行了化学和电化学，并且化合物已经通过 XRD 以及红外和拉曼光谱进行了表征。动电位和恒电流电化学研究表明，插层分两步进行，首先是在 2.84 处与锂金属相比发生结构变化，然后是在固溶体域中。该过程似乎部分可逆，并且该系统在每个过渡金属几乎 0.6 c 上表现出良好的循环行为。
• Vanadium Solid-Salt Battery
  申请人：Tohoku Techno Arch Co., Ltd.

  公开号：US20160093919A1

  公开（公告）日：2016-03-31

  The present disclosure relates to a vanadium solid-salt battery including: a power generating unit including first and second electrode members each containing vanadium, a separator separating the first and second electrode members from each other, and an electrolyte; a first sheet making contact with the first electrode member; a first flat plate-shaped conductive member making surface contact with the first sheet; a second sheet making contact with the second electrode member; a second flat plate-shaped conductive member making surface contact with the second sheet; a third sheet covering the first and second flat plate-shaped conductive members; and a first bonding portion bonding a peripheral portion of the third sheet so that at least portions of the first flat plate-shaped conductive member, the first sheet, the power generating unit, the second sheet and the second flat plate-shaped conductive member are pressure-bonded.

  本公开涉及一种钒固态盐电池，包括：发电单元，包括第一和第二电极成员，每个电极成员都含有钒，分离器将第一和第二电极成员分离，以及电解质；第一片与第一电极成员接触；第一扁平板状导电成员与第一片表面接触；第二片与第二电极成员接触；第二扁平板状导电成员与第二片表面接触；第三片覆盖第一和第二扁平板状导电成员；以及第一粘接部分将第三片的周边部分粘接，以使至少第一扁平板状导电成员、第一片、发电单元、第二片和第二扁平板状导电成员的部分被压合。
• α-VOSO4: a 2D-ferromagnet?
  作者：L. Lezama、G. Villeneuve、M.D. Marcos、J.L. Pizarro、P. Hagenmuller、T. Rojo

  DOI：10.1016/0038-1098(89)90291-3

  日期：1989.6

  Abstract A reexamination of the magnetic behavior of vanadyl sulfate α-VOSO 4 shows that the main magnetic interaction occurs within the layers through |SO 2- 4 | anions. The exchange constant is found to be positive ( J / k = +1.5K) involving ferromagnetic couplings in contrast to vanadyl phosphates which exhibit nearly the same geometry but whose exchange interactions are antiferromagnetic. An explanation

  摘要 对硫酸氧钒α-VOSO 4 磁行为的重新研究表明，主要的磁相互作用通过|SO 2- 4 |发生在层内。阴离子。发现交换常数为正 (J / k = +1.5K)，涉及铁磁耦合，而磷酸氧钒表现出几乎相同的几何形状，但其交换相互作用是反铁磁的。考虑到键角和反离子的性质，提出了一种解释。
• Krasil'nikov, V. N.; Glazyrin, M. P.; Ivakin, A. A., Russian Journal of Inorganic Chemistry, 1983, vol. 28, p. 1197 - 1200
  作者：Krasil'nikov, V. N.、Glazyrin, M. P.、Ivakin, A. A.

  DOI：——

  日期：——
• LASIEWICZ, KRYSTYNA
  作者：LASIEWICZ, KRYSTYNA

  DOI：——

  日期：——